

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 6.63567583 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.26499217 |
| 3 | fructose metabolic process (GO:0006000) | 6.11754764 |
| 4 | actin-myosin filament sliding (GO:0033275) | 6.01492441 |
| 5 | muscle filament sliding (GO:0030049) | 6.01492441 |
| 6 | short-term memory (GO:0007614) | 5.63200095 |
| 7 | skeletal muscle contraction (GO:0003009) | 5.41912722 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.37023076 |
| 9 | cerebellar granule cell differentiation (GO:0021707) | 4.99603810 |
| 10 | actin-mediated cell contraction (GO:0070252) | 4.73709144 |
| 11 | regulation of memory T cell differentiation (GO:0043380) | 4.65086016 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 4.57372882 |
| 13 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 4.56959027 |
| 14 | lymph node development (GO:0048535) | 4.52854134 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.51433714 |
| 16 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.46476659 |
| 17 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.36480770 |
| 18 | C4-dicarboxylate transport (GO:0015740) | 4.34230257 |
| 19 | auditory receptor cell stereocilium organization (GO:0060088) | 4.24585131 |
| 20 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 4.24013854 |
| 21 | striated muscle contraction (GO:0006941) | 4.20456509 |
| 22 | skeletal muscle fiber development (GO:0048741) | 4.18336500 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 4.15821549 |
| 24 | behavioral response to nicotine (GO:0035095) | 4.15001250 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.08008584 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 4.03219611 |
| 27 | myotube cell development (GO:0014904) | 3.76507083 |
| 28 | Peyers patch development (GO:0048541) | 3.75864302 |
| 29 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.75864302 |
| 30 | response to histamine (GO:0034776) | 3.62825883 |
| 31 | neurofilament cytoskeleton organization (GO:0060052) | 3.61726259 |
| 32 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.61123233 |
| 33 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.59947971 |
| 34 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.55841994 |
| 35 | cerebellar Purkinje cell layer development (GO:0021680) | 3.53588196 |
| 36 | relaxation of cardiac muscle (GO:0055119) | 3.51823727 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.51159455 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 3.51159455 |
| 39 | T-helper cell differentiation (GO:0042093) | 3.48988349 |
| 40 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.48988349 |
| 41 | neuromuscular synaptic transmission (GO:0007274) | 3.47909448 |
| 42 | muscle fiber development (GO:0048747) | 3.46022587 |
| 43 | oxidative phosphorylation (GO:0006119) | 3.45810654 |
| 44 | cellular response to sterol (GO:0036315) | 3.44548117 |
| 45 | metanephric tubule development (GO:0072170) | 3.44224948 |
| 46 | metanephric nephron tubule development (GO:0072234) | 3.44224948 |
| 47 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.43617552 |
| 48 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.42933565 |
| 49 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.41826643 |
| 50 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.40725224 |
| 51 | relaxation of muscle (GO:0090075) | 3.40339134 |
| 52 | cell differentiation in hindbrain (GO:0021533) | 3.38033588 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.37117027 |
| 54 | response to muscle activity (GO:0014850) | 3.34796900 |
| 55 | inositol phosphate-mediated signaling (GO:0048016) | 3.32843780 |
| 56 | actin filament-based movement (GO:0030048) | 3.31082961 |
| 57 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.28375372 |
| 58 | positive regulation of muscle hypertrophy (GO:0014742) | 3.27930314 |
| 59 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.27930314 |
| 60 | regulation of activation of Janus kinase activity (GO:0010533) | 3.27866511 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27263764 |
| 62 | cellular sodium ion homeostasis (GO:0006883) | 3.24814860 |
| 63 | sleep (GO:0030431) | 3.23654428 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 3.23418443 |
| 65 | muscle contraction (GO:0006936) | 3.21246032 |
| 66 | L-phenylalanine metabolic process (GO:0006558) | 3.21151679 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.21151679 |
| 68 | valine metabolic process (GO:0006573) | 3.18876439 |
| 69 | gluconeogenesis (GO:0006094) | 3.18227414 |
| 70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.15594833 |
| 71 | glutamate receptor signaling pathway (GO:0007215) | 3.14777372 |
| 72 | creatine metabolic process (GO:0006600) | 3.13916362 |
| 73 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.13365260 |
| 74 | metanephric nephron epithelium development (GO:0072243) | 3.11890171 |
| 75 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.10730203 |
| 76 | positive regulation of circadian rhythm (GO:0042753) | 3.10276798 |
| 77 | cardiac muscle contraction (GO:0060048) | 3.07370669 |
| 78 | macroautophagy (GO:0016236) | 3.06495295 |
| 79 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05467151 |
| 80 | nucleotide transmembrane transport (GO:1901679) | 3.05192149 |
| 81 | NADH metabolic process (GO:0006734) | 3.04425777 |
| 82 | neuron-neuron synaptic transmission (GO:0007270) | 3.03195339 |
| 83 | musculoskeletal movement (GO:0050881) | 3.01541211 |
| 84 | multicellular organismal movement (GO:0050879) | 3.01541211 |
| 85 | peripheral nervous system neuron development (GO:0048935) | 3.01317262 |
| 86 | prepulse inhibition (GO:0060134) | 3.01171748 |
| 87 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.01143191 |
| 88 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00719405 |
| 89 | plasma membrane repair (GO:0001778) | 2.99465169 |
| 90 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97714549 |
| 91 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.97127913 |
| 92 | detection of light stimulus involved in visual perception (GO:0050908) | 2.97127913 |
| 93 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.96139381 |
| 94 | membrane depolarization during action potential (GO:0086010) | 2.95725933 |
| 95 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.95634589 |
| 96 | viral protein processing (GO:0019082) | 2.95492906 |
| 97 | myofibril assembly (GO:0030239) | 2.94813760 |
| 98 | alpha-beta T cell activation (GO:0046631) | 2.92061824 |
| 99 | positive regulation of steroid hormone secretion (GO:2000833) | 2.90898899 |
| 100 | glycogen catabolic process (GO:0005980) | 2.90651666 |
| 101 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.89470056 |
| 102 | positive regulation of interleukin-17 production (GO:0032740) | 2.89319897 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.88884672 |
| 104 | postsynaptic membrane organization (GO:0001941) | 2.88676011 |
| 105 | hexose biosynthetic process (GO:0019319) | 2.87999267 |
| 106 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.87657847 |
| 107 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.87624210 |
| 108 | signal peptide processing (GO:0006465) | 2.86696913 |
| 109 | T cell differentiation involved in immune response (GO:0002292) | 2.86407587 |
| 110 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.86407587 |
| 111 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.86407587 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85236863 |
| 113 | muscle system process (GO:0003012) | 2.84552493 |
| 114 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.82900390 |
| 115 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.82900390 |
| 116 | metanephric epithelium development (GO:0072207) | 2.80732809 |
| 117 | peroxisome fission (GO:0016559) | 2.78348449 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 2.77091506 |
| 119 | aromatic amino acid family catabolic process (GO:0009074) | 2.77037388 |
| 120 | positive regulation of heat generation (GO:0031652) | 2.71828263 |
| 121 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.69391180 |
| 122 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.68209539 |
| 123 | regulation of timing of cell differentiation (GO:0048505) | 2.62870775 |
| 124 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.62177844 |
| 125 | neuromuscular process controlling posture (GO:0050884) | 2.61686812 |
| 126 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58252904 |
| 127 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58252904 |
| 128 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.57261614 |
| 129 | linoleic acid metabolic process (GO:0043651) | 2.56768297 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 2.52202673 |
| 131 | acylglycerol homeostasis (GO:0055090) | 2.51977024 |
| 132 | triglyceride homeostasis (GO:0070328) | 2.51977024 |
| 133 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.51584010 |
| 134 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.50696287 |
| 135 | vitamin catabolic process (GO:0009111) | 2.50259713 |
| 136 | fat-soluble vitamin catabolic process (GO:0042363) | 2.50259713 |
| 137 | coenzyme catabolic process (GO:0009109) | 2.49844506 |
| 138 | regulation of respiratory system process (GO:0044065) | 2.49208712 |
| 139 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.48392870 |
| 140 | interferon-gamma production (GO:0032609) | 2.48159903 |
| 141 | positive regulation of cell fate commitment (GO:0010455) | 2.46252965 |
| 142 | steroid catabolic process (GO:0006706) | 2.45080212 |
| 143 | neuronal action potential propagation (GO:0019227) | 2.44100883 |
| 144 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.42660283 |
| 145 | alpha-beta T cell differentiation (GO:0046632) | 2.42081315 |
| 146 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.41512681 |
| 147 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.41269363 |
| 148 | endocrine pancreas development (GO:0031018) | 2.37515261 |
| 149 | negative regulation of digestive system process (GO:0060457) | 2.37223540 |
| 150 | axoneme assembly (GO:0035082) | 2.36514545 |
| 151 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.35341236 |
| 152 | vitamin D metabolic process (GO:0042359) | 2.32292693 |
| 153 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.31620811 |
| 154 | lactate metabolic process (GO:0006089) | 2.29869761 |
| 155 | positive regulation of prostaglandin secretion (GO:0032308) | 2.28894731 |
| 156 | bile acid biosynthetic process (GO:0006699) | 2.26221166 |
| 157 | tryptophan metabolic process (GO:0006568) | 2.26074150 |
| 158 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.25971986 |
| 159 | regulation of heat generation (GO:0031650) | 2.25440762 |
| 160 | tolerance induction (GO:0002507) | 2.23987600 |
| 161 | startle response (GO:0001964) | 2.23914976 |
| 162 | regulation of fever generation (GO:0031620) | 2.23871653 |
| 163 | regulation of respiratory gaseous exchange (GO:0043576) | 2.22696084 |
| 164 | cellular response to interleukin-15 (GO:0071350) | 2.21714051 |
| 165 | purine nucleotide transport (GO:0015865) | 2.21670442 |
| 166 | adenine nucleotide transport (GO:0051503) | 2.20244265 |
| 167 | phospholipid efflux (GO:0033700) | 2.17420729 |
| 168 | indolalkylamine catabolic process (GO:0046218) | 2.17336585 |
| 169 | tryptophan catabolic process (GO:0006569) | 2.17336585 |
| 170 | indole-containing compound catabolic process (GO:0042436) | 2.17336585 |
| 171 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.16982175 |
| 172 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.16982175 |
| 173 | plasma lipoprotein particle organization (GO:0071827) | 2.16853524 |
| 174 | regulation of beta-amyloid formation (GO:1902003) | 2.16087774 |
| 175 | positive regulation of osteoclast differentiation (GO:0045672) | 2.15848102 |
| 176 | positive regulation of action potential (GO:0045760) | 2.15342983 |
| 177 | purine ribonucleotide transport (GO:0015868) | 2.14212145 |
| 178 | inositol phosphate catabolic process (GO:0071545) | 2.14144807 |
| 179 | innervation (GO:0060384) | 2.13926642 |
| 180 | sterol catabolic process (GO:0016127) | 2.12576477 |
| 181 | cholesterol catabolic process (GO:0006707) | 2.12576477 |
| 182 | protein-lipid complex assembly (GO:0065005) | 2.11102918 |
| 183 | response to interleukin-15 (GO:0070672) | 2.10597384 |
| 184 | nitrogen cycle metabolic process (GO:0071941) | 2.10039613 |
| 185 | amine catabolic process (GO:0009310) | 2.09737445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.72140552 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.79983836 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.52811277 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.91492851 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.75460536 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.26205526 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26130921 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.15376211 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12705863 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00400207 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97546950 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94646537 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.94283160 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91808793 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90494556 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87896532 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85746519 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85701399 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81855133 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81836967 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81616562 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80029717 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79992591 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79179961 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78748131 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77492260 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.77222863 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76579851 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76011595 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75672251 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73825233 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72158786 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69818357 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68756836 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68756836 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66861673 |
| 37 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65036623 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64144375 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58872362 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54928651 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54781737 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52403567 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51421731 |
| 44 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50853332 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50044077 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49115543 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48887176 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46300210 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44904129 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44708939 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44335136 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42034628 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41341340 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.40753446 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39818443 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38534097 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38118618 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37417987 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36405987 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34693185 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31768323 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30594045 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29257439 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28364476 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26965528 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26359980 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24925988 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24136977 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23574231 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23363413 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.23358000 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22387345 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22326357 |
| 74 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22055260 |
| 75 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.21630264 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21502814 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21229079 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19941794 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17266163 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17168870 |
| 81 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.16840361 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16404701 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15298359 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.15235353 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11592168 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11532276 |
| 87 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11473239 |
| 88 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10345519 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09884849 |
| 90 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09380533 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08045293 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07552706 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06247135 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05438429 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05414340 |
| 96 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03480507 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02954086 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02808533 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02653682 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01603283 |
| 101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01349809 |
| 102 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00855401 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00693936 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00628333 |
| 105 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.00430705 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00343015 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00312954 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00275924 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00114005 |
| 110 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99965048 |
| 111 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99931030 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99198520 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98697731 |
| 114 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98428851 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98009834 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97464877 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97242083 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96563087 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96212264 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95825845 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95648809 |
| 122 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95346820 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95122565 |
| 124 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94842294 |
| 125 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94735734 |
| 126 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94635452 |
| 127 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94377342 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94242830 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93636393 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93589413 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.93221245 |
| 132 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.93221245 |
| 133 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.92660571 |
| 134 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92570918 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92477172 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92458093 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90864429 |
| 138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90763265 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90346646 |
| 140 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89814921 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89413447 |
| 142 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89397863 |
| 143 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88157802 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88087219 |
| 145 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88087219 |
| 146 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87178540 |
| 147 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.86692569 |
| 148 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85519613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 4.97292269 |
| 2 | MP0003646_muscle_fatigue | 4.76989806 |
| 3 | MP0004036_abnormal_muscle_relaxation | 3.82677990 |
| 4 | MP0005365_abnormal_bile_salt | 3.77202795 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.57265065 |
| 6 | MP0000749_muscle_degeneration | 3.41708643 |
| 7 | MP0004742_abnormal_vestibular_system | 3.31784472 |
| 8 | MP0000751_myopathy | 3.18642935 |
| 9 | MP0003195_calcinosis | 2.92839906 |
| 10 | MP0005083_abnormal_biliary_tract | 2.91355561 |
| 11 | MP0001502_abnormal_circadian_rhythm | 2.70153563 |
| 12 | MP0001188_hyperpigmentation | 2.62606112 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.52457579 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.49924223 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44499635 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.31893152 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.30443749 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.29203565 |
| 19 | MP0004381_abnormal_hair_follicle | 2.21400042 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.20671222 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.14398812 |
| 22 | MP0000747_muscle_weakness | 2.03856781 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.02199397 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.01407214 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.95769679 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.95130525 |
| 27 | MP0000759_abnormal_skeletal_muscle | 1.93879695 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 1.93668218 |
| 29 | MP0004130_abnormal_muscle_cell | 1.89812937 |
| 30 | MP0005369_muscle_phenotype | 1.85278829 |
| 31 | MP0004484_altered_response_of | 1.85251511 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.85228414 |
| 33 | MP0004233_abnormal_muscle_weight | 1.78948601 |
| 34 | MP0003880_abnormal_central_pattern | 1.78376904 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.77817705 |
| 36 | MP0009745_abnormal_behavioral_response | 1.76381492 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.76031424 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.73673256 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.71933484 |
| 40 | MP0008872_abnormal_physiological_respon | 1.71665469 |
| 41 | MP0003724_increased_susceptibility_to | 1.71201841 |
| 42 | MP0005330_cardiomyopathy | 1.67986662 |
| 43 | MP0004142_abnormal_muscle_tone | 1.63756731 |
| 44 | MP0003011_delayed_dark_adaptation | 1.63499429 |
| 45 | MP0001984_abnormal_olfaction | 1.63090203 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.61311710 |
| 47 | MP0005409_darkened_coat_color | 1.60727461 |
| 48 | MP0009046_muscle_twitch | 1.59485065 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.54036396 |
| 50 | MP0002736_abnormal_nociception_after | 1.50381435 |
| 51 | MP0008569_lethality_at_weaning | 1.50346633 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.49918153 |
| 53 | MP0003868_abnormal_feces_composition | 1.48028563 |
| 54 | MP0004043_abnormal_pH_regulation | 1.47309563 |
| 55 | MP0002272_abnormal_nervous_system | 1.46319224 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.45631962 |
| 57 | MP0003137_abnormal_impulse_conducting | 1.43727940 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.42181321 |
| 59 | MP0001944_abnormal_pancreas_morphology | 1.38757665 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 1.38463988 |
| 61 | MP0002064_seizures | 1.36420515 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.35674859 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.34573631 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.33185733 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.32889901 |
| 66 | MP0004147_increased_porphyrin_level | 1.32163993 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.32053080 |
| 68 | MP0002269_muscular_atrophy | 1.31775602 |
| 69 | MP0009764_decreased_sensitivity_to | 1.31012635 |
| 70 | MP0005360_urolithiasis | 1.31003585 |
| 71 | MP0002693_abnormal_pancreas_physiology | 1.29163465 |
| 72 | MP0005647_abnormal_sex_gland | 1.29046534 |
| 73 | MP0003638_abnormal_response/metabolism_ | 1.27664564 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.27023924 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.24255769 |
| 76 | MP0003252_abnormal_bile_duct | 1.22941348 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.22884646 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.22671500 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.22289219 |
| 80 | MP0004270_analgesia | 1.20637132 |
| 81 | MP0002067_abnormal_sensory_capabilities | 1.20477057 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.19483074 |
| 83 | MP0001486_abnormal_startle_reflex | 1.19291313 |
| 84 | MP0005451_abnormal_body_composition | 1.17102687 |
| 85 | MP0005646_abnormal_pituitary_gland | 1.15102167 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 1.13465560 |
| 87 | MP0000015_abnormal_ear_pigmentation | 1.13107834 |
| 88 | MP0005535_abnormal_body_temperature | 1.12503737 |
| 89 | MP0008874_decreased_physiological_sensi | 1.12031946 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 1.11323099 |
| 91 | MP0002638_abnormal_pupillary_reflex | 1.09133690 |
| 92 | MP0002254_reproductive_system_inflammat | 1.07714517 |
| 93 | MP0002822_catalepsy | 1.07691640 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 1.07074637 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 1.06673515 |
| 96 | MP0005387_immune_system_phenotype | 1.05231562 |
| 97 | MP0001790_abnormal_immune_system | 1.05231562 |
| 98 | MP0002928_abnormal_bile_duct | 1.04517893 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 1.01952921 |
| 100 | MP0003878_abnormal_ear_physiology | 1.01952921 |
| 101 | MP0002132_abnormal_respiratory_system | 1.00160268 |
| 102 | MP0001970_abnormal_pain_threshold | 0.99688782 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.99100872 |
| 104 | MP0005671_abnormal_response_to | 0.99017297 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.97952140 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.97826648 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.97544566 |
| 108 | MP0004924_abnormal_behavior | 0.96869497 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.96869497 |
| 110 | MP0008057_abnormal_DNA_replication | 0.96862059 |
| 111 | MP0003866_abnormal_defecation | 0.96534114 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.95837239 |
| 113 | MP0003329_amyloid_beta_deposits | 0.94023036 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.93524068 |
| 115 | MP0004859_abnormal_synaptic_plasticity | 0.92731766 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.92498397 |
| 117 | MP0002184_abnormal_innervation | 0.92230430 |
| 118 | MP0008995_early_reproductive_senescence | 0.92052901 |
| 119 | MP0000613_abnormal_salivary_gland | 0.91821632 |
| 120 | MP0001270_distended_abdomen | 0.91253708 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.90770414 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.90520306 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.90440151 |
| 124 | MP0003953_abnormal_hormone_level | 0.89581133 |
| 125 | MP0002066_abnormal_motor_capabilities/c | 0.87560201 |
| 126 | MP0002127_abnormal_cardiovascular_syste | 0.87446625 |
| 127 | MP0000955_abnormal_spinal_cord | 0.87317900 |
| 128 | MP0001661_extended_life_span | 0.87067237 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.86554452 |
| 130 | MP0003136_yellow_coat_color | 0.86418323 |
| 131 | MP0003633_abnormal_nervous_system | 0.86063609 |
| 132 | MP0005174_abnormal_tail_pigmentation | 0.85978047 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.85103613 |
| 134 | MP0004885_abnormal_endolymph | 0.83833453 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.83469383 |
| 136 | MP0002229_neurodegeneration | 0.82649331 |
| 137 | MP0002933_joint_inflammation | 0.80444944 |
| 138 | MP0004085_abnormal_heartbeat | 0.77878922 |
| 139 | MP0001544_abnormal_cardiovascular_syste | 0.77872349 |
| 140 | MP0005385_cardiovascular_system_phenoty | 0.77872349 |
| 141 | MP0000566_synostosis | 0.77781717 |
| 142 | MP0003879_abnormal_hair_cell | 0.77389447 |
| 143 | MP0005334_abnormal_fat_pad | 0.77113460 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.77055102 |
| 145 | MP0001664_abnormal_digestion | 0.77007775 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.76617698 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.75431442 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.75074632 |
| 149 | MP0005410_abnormal_fertilization | 0.74445778 |
| 150 | MP0008775_abnormal_heart_ventricle | 0.72979640 |
| 151 | MP0001881_abnormal_mammary_gland | 0.72856886 |
| 152 | MP0003763_abnormal_thymus_physiology | 0.72402910 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.71379916 |
| 154 | MP0000579_abnormal_nail_morphology | 0.70996125 |
| 155 | MP0002108_abnormal_muscle_morphology | 0.70081860 |
| 156 | MP0003787_abnormal_imprinting | 0.67416245 |
| 157 | MP0005266_abnormal_metabolism | 0.64011646 |
| 158 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63521168 |
| 159 | MP0005332_abnormal_amino_acid | 0.59384383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 8.30310301 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.23707903 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.85226059 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.08730517 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.37449265 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 5.36158522 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.89210507 |
| 8 | Myopathic facies (HP:0002058) | 4.53387640 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.34969298 |
| 10 | Optic neuritis (HP:0100653) | 4.22198286 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.22198286 |
| 12 | Dysmetric saccades (HP:0000641) | 4.21986955 |
| 13 | Distal arthrogryposis (HP:0005684) | 4.18152533 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.10727992 |
| 15 | Focal motor seizures (HP:0011153) | 3.99116884 |
| 16 | Myoglobinuria (HP:0002913) | 3.90692208 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.87992188 |
| 18 | Hypoglycemic seizures (HP:0002173) | 3.80840286 |
| 19 | Orchitis (HP:0100796) | 3.77937119 |
| 20 | Absence seizures (HP:0002121) | 3.74025139 |
| 21 | Symptomatic seizures (HP:0011145) | 3.63102680 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.56418181 |
| 23 | Hypothermia (HP:0002045) | 3.54414491 |
| 24 | Febrile seizures (HP:0002373) | 3.49242133 |
| 25 | Scanning speech (HP:0002168) | 3.37040667 |
| 26 | Horizontal nystagmus (HP:0000666) | 3.32192297 |
| 27 | Ulnar deviation of the wrist (HP:0003049) | 3.30475581 |
| 28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.27050473 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.25451568 |
| 30 | Stomatitis (HP:0010280) | 3.20067170 |
| 31 | Bulbar palsy (HP:0001283) | 3.16901702 |
| 32 | Dysdiadochokinesis (HP:0002075) | 3.12287700 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.09976565 |
| 34 | Abnormality of the neuromuscular junction (HP:0003398) | 3.09313535 |
| 35 | Fatigable weakness (HP:0003473) | 3.09313535 |
| 36 | Progressive cerebellar ataxia (HP:0002073) | 3.05506634 |
| 37 | Areflexia of lower limbs (HP:0002522) | 3.04818837 |
| 38 | Round ear (HP:0100830) | 3.03048648 |
| 39 | Myositis (HP:0100614) | 3.00814012 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.98680115 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.98658075 |
| 42 | Rimmed vacuoles (HP:0003805) | 2.98632452 |
| 43 | Hyporeflexia of lower limbs (HP:0002600) | 2.97137694 |
| 44 | Frequent falls (HP:0002359) | 2.96969761 |
| 45 | Bundle branch block (HP:0011710) | 2.96860872 |
| 46 | Abnormality of the calf musculature (HP:0001430) | 2.96272023 |
| 47 | Myotonia (HP:0002486) | 2.92939492 |
| 48 | Facial diplegia (HP:0001349) | 2.91209226 |
| 49 | Chronic hepatic failure (HP:0100626) | 2.86688050 |
| 50 | Neck muscle weakness (HP:0000467) | 2.83745154 |
| 51 | Hyperglycemia (HP:0003074) | 2.81404445 |
| 52 | Sudden death (HP:0001699) | 2.81285496 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.72144320 |
| 54 | Muscle fiber splitting (HP:0003555) | 2.71993051 |
| 55 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.68751007 |
| 56 | Subaortic stenosis (HP:0001682) | 2.68751007 |
| 57 | Truncal ataxia (HP:0002078) | 2.68244383 |
| 58 | Malignant hyperthermia (HP:0002047) | 2.65443146 |
| 59 | Muscle stiffness (HP:0003552) | 2.59829840 |
| 60 | Depressed nasal tip (HP:0000437) | 2.57136727 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.54160573 |
| 62 | Submucous cleft hard palate (HP:0000176) | 2.52848349 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.51062860 |
| 64 | Intestinal atresia (HP:0011100) | 2.50249461 |
| 65 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.50115500 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.45341105 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.38812276 |
| 68 | Prolonged partial thromboplastin time (HP:0003645) | 2.38633742 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.37740273 |
| 70 | Myokymia (HP:0002411) | 2.36763866 |
| 71 | Hyperventilation (HP:0002883) | 2.34606715 |
| 72 | Acute necrotizing encephalopathy (HP:0006965) | 2.33152724 |
| 73 | Genetic anticipation (HP:0003743) | 2.32433333 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.30266177 |
| 75 | Hyperkalemia (HP:0002153) | 2.30047859 |
| 76 | Joint hemorrhage (HP:0005261) | 2.29253366 |
| 77 | Abnormal ciliary motility (HP:0012262) | 2.27425515 |
| 78 | Split foot (HP:0001839) | 2.26990593 |
| 79 | Ketoacidosis (HP:0001993) | 2.25706264 |
| 80 | Broad-based gait (HP:0002136) | 2.25253719 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23841759 |
| 82 | Distal lower limb amyotrophy (HP:0008944) | 2.22726348 |
| 83 | Enlarged kidneys (HP:0000105) | 2.22527253 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20909439 |
| 85 | Impaired smooth pursuit (HP:0007772) | 2.20763655 |
| 86 | Hypoplasia of the fovea (HP:0007750) | 2.19843366 |
| 87 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.19843366 |
| 88 | Rhinitis (HP:0012384) | 2.19807150 |
| 89 | Heart block (HP:0012722) | 2.19707997 |
| 90 | White forelock (HP:0002211) | 2.18692057 |
| 91 | Postural tremor (HP:0002174) | 2.18345844 |
| 92 | EMG: neuropathic changes (HP:0003445) | 2.18099273 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18095240 |
| 94 | Abnormal hair whorl (HP:0010721) | 2.17278971 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 2.15174250 |
| 96 | Renal cortical cysts (HP:0000803) | 2.14848639 |
| 97 | Weak cry (HP:0001612) | 2.13806316 |
| 98 | Pulmonary infiltrates (HP:0002113) | 2.13338092 |
| 99 | Optic nerve hypoplasia (HP:0000609) | 2.11923306 |
| 100 | Absent phalangeal crease (HP:0006109) | 2.11359408 |
| 101 | Oligodactyly (hands) (HP:0001180) | 2.11136958 |
| 102 | Widely patent fontanelles and sutures (HP:0004492) | 2.10848600 |
| 103 | Generalized muscle weakness (HP:0003324) | 2.10658656 |
| 104 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10040107 |
| 105 | Calcaneovalgus deformity (HP:0001848) | 2.09626700 |
| 106 | Blue irides (HP:0000635) | 2.09268711 |
| 107 | Difficulty running (HP:0009046) | 2.09169730 |
| 108 | Atonic seizures (HP:0010819) | 2.09087499 |
| 109 | Dysmetria (HP:0001310) | 2.08542551 |
| 110 | Opisthotonus (HP:0002179) | 2.08453787 |
| 111 | Exercise intolerance (HP:0003546) | 2.07946641 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.05885098 |
| 113 | Progressive muscle weakness (HP:0003323) | 2.05683237 |
| 114 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.05619334 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05552236 |
| 116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03382833 |
| 117 | Enlarged epiphyses (HP:0010580) | 2.03118258 |
| 118 | Proximal amyotrophy (HP:0007126) | 2.01578620 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 2.01456158 |
| 120 | Progressive inability to walk (HP:0002505) | 2.00607452 |
| 121 | Mitochondrial inheritance (HP:0001427) | 1.98905205 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.98884119 |
| 123 | Patchy hypopigmentation of hair (HP:0011365) | 1.96014769 |
| 124 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.95360587 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.95190712 |
| 126 | Abnormal atrioventricular conduction (HP:0005150) | 1.94433618 |
| 127 | Focal seizures (HP:0007359) | 1.94023167 |
| 128 | Acute encephalopathy (HP:0006846) | 1.93980393 |
| 129 | Hypophosphatemia (HP:0002148) | 1.93254179 |
| 130 | Osteomalacia (HP:0002749) | 1.92362083 |
| 131 | Gowers sign (HP:0003391) | 1.92100198 |
| 132 | Epileptiform EEG discharges (HP:0011182) | 1.91152205 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.90893876 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.90284691 |
| 135 | Ketosis (HP:0001946) | 1.89671170 |
| 136 | Type 2 muscle fiber atrophy (HP:0003554) | 1.89173384 |
| 137 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.88901475 |
| 138 | Acne (HP:0001061) | 1.87607307 |
| 139 | EEG with generalized epileptiform discharges (HP:0011198) | 1.87089761 |
| 140 | Abnormality of saccadic eye movements (HP:0000570) | 1.86314710 |
| 141 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85978623 |
| 142 | Epidermoid cyst (HP:0200040) | 1.85423855 |
| 143 | Abnormality of binocular vision (HP:0011514) | 1.85281083 |
| 144 | Diplopia (HP:0000651) | 1.85281083 |
| 145 | Ragged-red muscle fibers (HP:0003200) | 1.84527648 |
| 146 | Hypsarrhythmia (HP:0002521) | 1.84308448 |
| 147 | Easy fatigability (HP:0003388) | 1.81975538 |
| 148 | Hyperglycinuria (HP:0003108) | 1.81953395 |
| 149 | Delayed CNS myelination (HP:0002188) | 1.81417609 |
| 150 | Dialeptic seizures (HP:0011146) | 1.81404764 |
| 151 | Renal dysplasia (HP:0000110) | 1.81027567 |
| 152 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80921797 |
| 153 | Increased serum pyruvate (HP:0003542) | 1.80721982 |
| 154 | Prolonged QT interval (HP:0001657) | 1.80614353 |
| 155 | Median cleft lip (HP:0000161) | 1.80476868 |
| 156 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80144165 |
| 157 | Intention tremor (HP:0002080) | 1.78977503 |
| 158 | Pancreatitis (HP:0001733) | 1.78265599 |
| 159 | Limb ataxia (HP:0002070) | 1.78038326 |
| 160 | Increased connective tissue (HP:0009025) | 1.77315835 |
| 161 | Deformed tarsal bones (HP:0008119) | 1.76552313 |
| 162 | Abnormality of the nasal septum (HP:0000419) | 1.75650796 |
| 163 | Joint swelling (HP:0001386) | 1.74661460 |
| 164 | Action tremor (HP:0002345) | 1.74570090 |
| 165 | Hypoplasia of the thymus (HP:0000778) | 1.74472884 |
| 166 | Encephalitis (HP:0002383) | 1.74386562 |
| 167 | Anorexia (HP:0002039) | 1.72787303 |
| 168 | Epileptic encephalopathy (HP:0200134) | 1.70298017 |
| 169 | Decreased circulating renin level (HP:0003351) | 1.69821073 |
| 170 | Generalized aminoaciduria (HP:0002909) | 1.69209152 |
| 171 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.68788352 |
| 172 | T lymphocytopenia (HP:0005403) | 1.68643972 |
| 173 | Meningitis (HP:0001287) | 1.68630456 |
| 174 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.67777436 |
| 175 | Thyroiditis (HP:0100646) | 1.67682798 |
| 176 | Abnormality of methionine metabolism (HP:0010901) | 1.67272389 |
| 177 | Muscle fiber atrophy (HP:0100295) | 1.64414114 |
| 178 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.64231861 |
| 179 | Conjugated hyperbilirubinemia (HP:0002908) | 1.63734464 |
| 180 | Progressive hearing impairment (HP:0001730) | 1.63358208 |
| 181 | Fetal akinesia sequence (HP:0001989) | 1.63277958 |
| 182 | Pulmonary embolism (HP:0002204) | 1.62575703 |
| 183 | Cheilitis (HP:0100825) | 1.61976069 |
| 184 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.61580352 |
| 185 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.61359411 |
| 186 | Abnormal platelet function (HP:0011869) | 1.60700421 |
| 187 | Impaired platelet aggregation (HP:0003540) | 1.60700421 |
| 188 | Gangrene (HP:0100758) | 1.60353136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.72856014 |
| 2 | TAOK3 | 4.46791010 |
| 3 | TXK | 4.32617910 |
| 4 | INSRR | 3.40488868 |
| 5 | IRAK3 | 3.27370135 |
| 6 | TTN | 2.64012133 |
| 7 | MAPK15 | 2.36863423 |
| 8 | TNIK | 2.31051156 |
| 9 | CASK | 2.19869367 |
| 10 | NTRK3 | 2.13323432 |
| 11 | GRK6 | 2.12607177 |
| 12 | FRK | 2.08418476 |
| 13 | SGK2 | 2.02331923 |
| 14 | VRK2 | 1.89332923 |
| 15 | DAPK2 | 1.87286243 |
| 16 | MAP3K12 | 1.86699127 |
| 17 | MUSK | 1.84666368 |
| 18 | AKT3 | 1.79963144 |
| 19 | TEC | 1.79349064 |
| 20 | PIK3CG | 1.74062475 |
| 21 | PRPF4B | 1.70122593 |
| 22 | GRK7 | 1.63802213 |
| 23 | BMPR2 | 1.55757156 |
| 24 | SGK223 | 1.53013730 |
| 25 | SGK494 | 1.53013730 |
| 26 | TIE1 | 1.46073965 |
| 27 | ITK | 1.45276128 |
| 28 | ARAF | 1.39385695 |
| 29 | NTRK2 | 1.36806237 |
| 30 | TSSK6 | 1.35045299 |
| 31 | MST4 | 1.34424159 |
| 32 | BTK | 1.31447490 |
| 33 | WNK1 | 1.30342965 |
| 34 | MAP3K9 | 1.29474596 |
| 35 | TNK2 | 1.27031226 |
| 36 | SGK3 | 1.25632225 |
| 37 | STK24 | 1.21251118 |
| 38 | HIPK2 | 1.16877431 |
| 39 | MAP3K14 | 1.16513813 |
| 40 | VRK1 | 1.08695982 |
| 41 | GRK1 | 1.08218660 |
| 42 | MAP2K2 | 1.07135773 |
| 43 | YES1 | 1.06116497 |
| 44 | PDK2 | 1.04541961 |
| 45 | EPHA4 | 1.04499713 |
| 46 | SIK3 | 1.04391565 |
| 47 | NEK6 | 1.00233732 |
| 48 | MAP2K4 | 0.99332521 |
| 49 | LIMK1 | 0.97946772 |
| 50 | IRAK4 | 0.97700978 |
| 51 | SIK1 | 0.95233162 |
| 52 | EIF2AK2 | 0.92500624 |
| 53 | JAK1 | 0.91524833 |
| 54 | NEK1 | 0.90836692 |
| 55 | WNK4 | 0.90172349 |
| 56 | MKNK2 | 0.89054686 |
| 57 | IKBKE | 0.87858887 |
| 58 | PASK | 0.86320014 |
| 59 | LMTK2 | 0.84617884 |
| 60 | ADRBK2 | 0.83373175 |
| 61 | SYK | 0.82967900 |
| 62 | MAPK13 | 0.81808433 |
| 63 | TESK1 | 0.81041102 |
| 64 | PRKCQ | 0.80534089 |
| 65 | RPS6KB1 | 0.79893736 |
| 66 | MAP2K7 | 0.78742098 |
| 67 | MAP3K2 | 0.77687779 |
| 68 | CAMKK2 | 0.77060238 |
| 69 | TRPM7 | 0.75015977 |
| 70 | MAP3K13 | 0.74359826 |
| 71 | MYLK | 0.72269123 |
| 72 | PINK1 | 0.71332993 |
| 73 | TAOK2 | 0.70961854 |
| 74 | PRKAA1 | 0.70822580 |
| 75 | SIK2 | 0.70516388 |
| 76 | PRKCE | 0.67178551 |
| 77 | MARK1 | 0.66763696 |
| 78 | MAPKAPK3 | 0.66709405 |
| 79 | ZAP70 | 0.65560454 |
| 80 | CDC42BPA | 0.64231036 |
| 81 | GRK5 | 0.64036314 |
| 82 | PDK1 | 0.63711110 |
| 83 | CDK3 | 0.63416445 |
| 84 | JAK3 | 0.61496265 |
| 85 | PHKG2 | 0.60827879 |
| 86 | PHKG1 | 0.60827879 |
| 87 | LATS1 | 0.60565254 |
| 88 | ZAK | 0.60075126 |
| 89 | IKBKB | 0.59593861 |
| 90 | ERBB3 | 0.59587418 |
| 91 | ERBB4 | 0.58022000 |
| 92 | CAMK1 | 0.57933011 |
| 93 | NUAK1 | 0.57842033 |
| 94 | CSNK1A1L | 0.54081639 |
| 95 | FGFR3 | 0.53797467 |
| 96 | MAPK4 | 0.53712447 |
| 97 | IGF1R | 0.51905028 |
| 98 | MST1R | 0.51853310 |
| 99 | CHUK | 0.51471937 |
| 100 | MAP4K1 | 0.51374928 |
| 101 | MAPK7 | 0.51304859 |
| 102 | MAP3K7 | 0.50992061 |
| 103 | WNK3 | 0.48664940 |
| 104 | PRKACA | 0.47789049 |
| 105 | DYRK1A | 0.46514302 |
| 106 | MAP3K4 | 0.45460895 |
| 107 | CAMK4 | 0.44713070 |
| 108 | RPS6KA3 | 0.44559359 |
| 109 | IRAK1 | 0.44548346 |
| 110 | TBK1 | 0.43706117 |
| 111 | CSK | 0.43596927 |
| 112 | PRKG1 | 0.43409447 |
| 113 | CAMK2G | 0.42989419 |
| 114 | SGK1 | 0.42946733 |
| 115 | PRKAA2 | 0.41376563 |
| 116 | PRKCG | 0.41270365 |
| 117 | CSNK1G3 | 0.41194381 |
| 118 | KIT | 0.41118362 |
| 119 | PRKCA | 0.39574388 |
| 120 | FGFR4 | 0.39232378 |
| 121 | NME1 | 0.38846447 |
| 122 | MAP2K3 | 0.38755551 |
| 123 | PKN1 | 0.38237940 |
| 124 | IRAK2 | 0.38027981 |
| 125 | FES | 0.37917560 |
| 126 | MAP2K6 | 0.37649805 |
| 127 | PRKCH | 0.37257298 |
| 128 | CSNK1G1 | 0.36157124 |
| 129 | CAMK1G | 0.35819781 |
| 130 | JAK2 | 0.35245916 |
| 131 | CAMKK1 | 0.35051309 |
| 132 | LCK | 0.34844095 |
| 133 | MAPK12 | 0.34266398 |
| 134 | BRAF | 0.33978620 |
| 135 | PRKACG | 0.33843784 |
| 136 | MINK1 | 0.33222787 |
| 137 | CAMK2A | 0.33147626 |
| 138 | FER | 0.33105140 |
| 139 | UHMK1 | 0.32387655 |
| 140 | PIK3CA | 0.32246564 |
| 141 | CAMK2D | 0.32117482 |
| 142 | CDK5 | 0.31222669 |
| 143 | MAPK3 | 0.31183514 |
| 144 | EIF2AK3 | 0.30355312 |
| 145 | CSNK1G2 | 0.27572681 |
| 146 | MAP4K2 | 0.24369347 |
| 147 | FYN | 0.23795442 |
| 148 | CSNK1D | 0.23358361 |
| 149 | CSNK1A1 | 0.22893309 |
| 150 | PRKG2 | 0.22261509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.05898412 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 3.76536097 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.34849824 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67347904 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.36181637 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30348483 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.15654853 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13764884 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.10336819 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07150014 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.01134709 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96373613 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85786891 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79539100 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72990862 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.69136363 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68823851 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68546837 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.68184608 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67412454 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.58504629 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.55524581 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49110262 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.47987063 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.43978474 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42956238 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36605390 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.31190711 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30343255 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30293305 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28261827 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.28255915 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26296001 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25125203 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23280297 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.22792354 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.22490871 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22071235 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20444216 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19801661 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18958071 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18390829 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.18084415 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16799907 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16575638 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13951320 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13695881 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13249077 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11749547 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10831657 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08969632 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08298825 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06099601 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.04854041 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02778685 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02111663 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.00097013 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99405777 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99254619 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98960884 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98621028 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97797587 |
| 63 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94466427 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94439033 |
| 65 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93801978 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93698506 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92741760 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91360974 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90087918 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89858905 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89520035 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88992606 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88238579 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87644438 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.86031558 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84872518 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84664851 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83537025 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79542901 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79121273 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78552492 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77805210 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77698267 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77621987 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77573975 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.74722969 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74091524 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.72361352 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71826637 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69852368 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68515488 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68270296 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67739611 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66748055 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64409238 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63446659 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62825694 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62340598 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61126019 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61076296 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60976840 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60847644 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60039571 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59400256 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.59226214 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59063279 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56811631 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56609941 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55487109 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54853145 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54682223 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.54363529 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53472536 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52634686 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52490735 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52392984 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52255840 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50555217 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49581390 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48794118 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48327025 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48297758 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.46482800 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46307495 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.46053303 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45821787 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44960333 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44721416 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.44211378 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42466593 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40770275 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40725170 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39018827 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38914152 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38711479 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36575560 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32871148 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32832412 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.31990010 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30358489 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30299600 |
| 142 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.30129967 |
| 143 | Gap junction_Homo sapiens_hsa04540 | 0.29014199 |
| 144 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23917904 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22154656 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19229326 |

